Casey Woodring
Stock Analyst at JP Morgan
(0.12)
# 3,899
Out of 4,667 analysts
28
Total ratings
12.5%
Success rate
-26.02%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $78.04 | +20.45% | 5 | Nov 5, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $375 → $280 | $203.67 | +37.48% | 4 | Oct 25, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | $270 → $205 | $187.90 | +9.10% | 5 | Aug 8, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $52 → $54 | $42.09 | +28.30% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.81 | +57.48% | 3 | May 13, 2024 | |
| QDEL QuidelOrtho | Downgrades: Underweight | $66 → $37 | $37.48 | -1.28% | 3 | Feb 14, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $28.26 | -18.61% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $13.21 | +36.26% | 2 | Jan 23, 2023 |
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $78.04
Upside: +20.45%
ICON Public Limited Company
Oct 25, 2024
Maintains: Overweight
Price Target: $375 → $280
Current: $203.67
Upside: +37.48%
Charles River Laboratories International
Aug 8, 2024
Downgrades: Neutral
Price Target: $270 → $205
Current: $187.90
Upside: +9.10%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $52 → $54
Current: $42.09
Upside: +28.30%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.81
Upside: +57.48%
QuidelOrtho
Feb 14, 2024
Downgrades: Underweight
Price Target: $66 → $37
Current: $37.48
Upside: -1.28%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $28.26
Upside: -18.61%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $13.21
Upside: +36.26%